Fundamental Research
Understanding basic biology and the cause of human disease
Translational Research
Advancing research to clinical breakthroughs for patients through drug discovery and collaborations
Education & Training
Cultivating the next generation of scientists through our graduate school, postdoctoral training programs and fellowships
The Latest News
-
After a career of exploring how viruses wreak havoc on our health, researcher now becomes a “subject” in a vaccine study. -
Bioinformatics platform simplifies data analysis to help biologists glean scientific insights into the novel coronavirus as body of data surges. -
Funding awarded to scientists at Sanford Burnham Prebys, Camino Pharma and UC San Diego propels drug candidate through first-in-human studies. -
Drug Discovery
Sanford Burnham Prebys receives $3 million NIH award for drugs that restore immune response to COVID-19
Scientists will study how SARS-CoV-19 hijacks the immune system and creates a “cytokine storm” -
The study reveals a promising new therapeutic approach for the incurable muscle-wasting condition. -
Graduate school dean Guy Salvesen describes barriers he has seen for students who are Black and how we can make science fully inclusive. -
Discovery opens new research avenues that may help catch cancer early and identify potential preventive treatments. -
Drug Discovery
San Diego’s pandemic stories
We asked 16 locals—from students to nurses, hoteliers and store owners—how they're working through the pandemic and helping others. -
Scientists at Sanford Burnham Prebys Medical Discovery Institute discovered that inhibiting a protein called PPP1R1B could reduce the deadly spread of pancreatic cancer in mice. -
Drug Discovery
Sanford Burnham Prebys awarded $4.5 million NIH grant for mental illness therapeutics
The funding supports the discovery of new classes of drugs that target “orphan” receptors to treat psychological conditions such as schizophrenia, depression, anxiety and substance abuse. -
The findings are a first step toward a potential treatment for one of the deadliest cancers known today. -
Researchers are hoping the study shows how coronavirus affects people from different backgrounds.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Next Generation
ACS awards Sanford Burnham Prebys scientist Research Scholar Grant
The American Cancer Society (ACS) has awarded Brooke Emering, Ph.D., assistant professor in our Cancer, Molecules and Structures Program, a highly competitive Research Scholar Grant.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
COVID-19 matching gift campaign
The power of investing in human health
Dinah Ruch is accelerating our COVID-19 efforts with a generous matching gift that doubles all donations dollar for dollar up to $500,000.
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
